LONGBOARD PHARMACEUTICALS IN's ticker is LBPH and the CUSIP is 54300N103. A total of 22 filers reported holding LONGBOARD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,855 | -20.6% | 1,772,348 | +4.8% | 0.00% | -50.0% |
| Q2 2023 | $12,416 | +115.7% | 1,691,330 | +15.5% | 0.00% | +100.0% |
| Q1 2023 | $5,757 | +20.6% | 1,464,774 | -3.1% | 0.00% | 0.0% |
| Q4 2022 | $4,775 | -99.9% | 1,510,961 | +0.1% | 0.00% | 0.0% |
| Q3 2022 | $5,617,000 | +20.3% | 1,509,775 | -0.1% | 0.00% | 0.0% |
| Q2 2022 | $4,671,000 | -40.5% | 1,511,739 | -0.0% | 0.00% | 0.0% |
| Q1 2022 | $7,849,000 | -19.9% | 1,512,239 | -25.3% | 0.00% | 0.0% |
| Q4 2021 | $9,799,000 | -51.9% | 2,024,616 | -11.4% | 0.00% | -50.0% |
| Q3 2021 | $20,362,000 | +1.3% | 2,285,290 | -0.1% | 0.00% | 0.0% |
| Q2 2021 | $20,105,000 | -44.5% | 2,287,289 | -0.7% | 0.00% | -50.0% |
| Q1 2021 | $36,230,000 | – | 2,302,749 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,273,221 | $11,069,000 | 0.66% |
| Integral Health Asset Management, LLC | 30,000 | $146,000 | 0.04% |
| FARALLON CAPITAL MANAGEMENT LLC | 810,500 | $3,923,000 | 0.02% |
| Orbimed Advisors | 113,500 | $554,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 70,000 | $339,000 | 0.01% |
| Alyeska Investment Group, L.P. | 62,500 | $305,000 | 0.00% |
| Veritable, L.P. | 20,534 | $100,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 225,557 | $1,092,000 | 0.00% |
| FMR LLC | 1,515,583 | $7,336,000 | 0.00% |
| CITIGROUP INC | 200,000 | $968,000 | 0.00% |